M2S Announces New Clinical Trial Product, iMAS, A Medical Image Collect And Hold Solution

M2S Announces New Clinical Trial Product, iMAS, A Medical Image Collect And Hold Solution

M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, today announced that it has launched a new product to collect and hold medical images in clinical trials, called iMAS (Image Management Archive System). iMAS is a cost-effective option for clinical trial sponsors to centralize the collection of the large imaging data sets frequently utilized in clinical trials, while giving them accessibility and secure storage, with minimal investment.

West Lebanon, NH (PRWEB) -- M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, today announced that it has launched a new product to collect and hold medical images in clinical trials, called iMAS (Image Management Archive System). iMAS is a cost-effective option for clinical trial sponsors to centralize the collection of the large imaging data sets frequently utilized in clinical trials, while giving them accessibility and secure storage, with minimal investment.

"Clinical trial sponsors are facing extraordinary cost pressures in the current economy," said Wes Chapman, CEO of M2S. "With less time needed for setup, decreased trial complexity and reduced documentation requirements, an M2S iMAS trial is typically only 20% of the cost of a full clinical trial. This option gives trial sponsors the control and flexibility to adjust a trial and add a blinded radiological review at any point, while simultaneously containing costs."

While many clinical trials continue to incorporate imaging data for surrogate endpoints, it is not always clear whether or not image data review and submission will be necessary. However, potentially valuable and expensive imaging data can and probably should still be collected. Sponsors may want to consider using those images for a later submission, subsequent trials or for patient registries, and the risk, cost and effort of retrospectively collecting images can exceed that of prospective medical image collection.

M2S will customize the iMAS product based on service levels needed for a particular clinical trial - including consultation, project management and query management. Real-time, web-based reports allow sponsors to see both the status of data gathered as well as access the data anytime, anywhere. Transparency and flexibility for the sponsor, as well as the ability to reduce a sponsor's risk through proactive image management strategies, are the cornerstones of iMAS' success.

About M2S, Inc.
M2S offers medical image data management services across the healthcare continuum based on best-in-class technology and continuous quality improvement processes. M2S clinical trial image management services include protocol development, electronic image collection, independent review, archive and real-time web-based data access. M2S clinical data registries provide long-term evaluation of treatment outcomes, benefits and cost. All services focus on increasing operational efficiency, reducing total cost and maintaining or enhancing clinical quality. For more information, visit www.m2s.com

Suggested Articles

Cedrik Britten, M.D., becomes the biotech’s new chief medical officer to help run its adoptive cell therapy and TCR bispecifics platform.

Broad Institute researchers showed that base-editing the Tmc1 gene preserved hair cells that helped transmit sound in the ears of mice.

Five Prime Therapeutics’ clinical development lead is hoping for a more stable time at new employer Spectrum Pharma.